Revista: Therapeutics and Clinical Risk Management
Resumen: to estimate the unit costs of administering intravenous (IV) biological agents in day hospitals (DHs) in the Spanish National Health System. Conclusion: The average total cost of infusion was less than that normally used in models of economic evaluation coming from secondary sources. This cost is even less when the staff costs are imputed according to the PIM. A high degree of variability was observed between different DHs in the cost of the consumables, in the structure-related costs, and in those of the care process.
Cómo citar: Nolla, J. M., Martin, E., Llamas, P., Manero, J., de la Serna, A. R., Fernández-Miera, M. F., … & Aragón, B. (2017). An estimate of the cost of administering intravenous biological agents in Spanish day hospitals. Therapeutics and clinical risk management, 13, 325.